Emergent BioSolutions Inc.
EBSNYSECIK 1367644HealthcareFiscal year ends Dec 31
Reports and events: 402 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1611:48 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001367644-26-000098 |
| 2026-09-1420:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-26-000091 |
| 2026-09-0120:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-26-000088 |
| 2026-08-0621:47 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001367644-26-000082 |
| 2026-08-0520:06 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-26-000080 |
| 2026-06-2915:14 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-26-000068 |
| 2026-05-0121:54 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001367644-26-000065 |
| 2026-04-3020:32 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-26-000059 |
| 2026-04-3011:30 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001367644-26-000051 |
| 2026-04-1721:51 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-26-000038 |
| 2026-03-2020:51 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001367644-26-000033 |
| 2026-03-0313:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-26-000019 |
| 2026-02-2722:46 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001367644-26-000015 |
| 2026-02-2621:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-26-000012 |
| 2026-01-1422:13 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-013061 |
| 2026-01-1212:51 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-26-000003 |
| 2025-12-1213:29 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-25-000207 |
| 2025-11-1221:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-25-000204 |
| 2025-10-3021:38 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001367644-25-000202 |
| 2025-10-2920:19 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-25-000198 |
| 2025-09-1120:07 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-25-000188 |
| 2025-09-0521:23 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-25-000183 |
| 2025-08-0721:50 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001367644-25-000181 |
| 2025-08-0620:13 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-25-000179 |
| 2025-06-2420:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-25-000153 |
| 2025-05-2320:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-25-000133 |
| 2025-05-0821:46 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001367644-25-000124 |
| 2025-05-0720:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-25-000121 |
| 2025-05-0620:19 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001367644-25-000114 |
| 2025-03-3112:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-25-000087 |
| 2025-03-2421:34 ET | 8-K | 8.01 Other events | 0001367644-25-000083 |
| 2025-03-2120:37 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001367644-25-000080 |
| 2025-03-1020:47 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-25-000054 |
| 2025-03-0422:41 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001367644-25-000021 |
| 2025-03-0321:27 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-25-000019 |
| 2025-01-1520:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-007008 |
| 2025-01-1413:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-25-000010 |
| 2025-01-0822:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-25-000004 |
| 2024-12-0221:36 ET | S-1/A | Registration statement, amended | 0001193125-24-268963 |
| 2024-11-1221:06 ET | S-1 | Registration statement | 0001193125-24-255932 |
| 2024-11-0722:46 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001367644-24-000178 |
| 2024-11-0621:12 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-24-000176 |
| 2024-10-0411:29 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001367644-24-000161 |
| 2024-10-0212:11 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-230710 |
| 2024-09-1720:12 ET | 8-K | 3.02 Unregistered sale of equity | 0001367644-24-000158 |
| 2024-09-0311:47 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-211548 |
| 2024-08-3000:26 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-24-000155 |
| 2024-08-2020:20 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-24-000152 |
| 2024-08-0721:37 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001367644-24-000147 |
| 2024-08-0620:21 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-24-000142 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.